Chen Liang
Impact in
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
Papers in
- Oncology 41
- Pancreatic and Hepatic Oncology Research 37
- Cancer Immunotherapy and Biomarkers 3
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 5
- Co-authors
- Xianjun Yu (72 shared papers)Si Shi (68 shared papers)Jin Xu (64 shared papers)Qingcai Meng (56 shared papers)Jie Hua (49 shared papers)Jiang Liu (19 shared papers)Bo Zhang (19 shared papers)Wei Wang (20 shared papers)
- Journals
- Frontiers in Oncology (5 papers)Cell Death and Disease (5 papers)Molecular Cancer (4 papers)Journal of Biological Chemistry (4 papers)International Journal of Molecular Sciences (3 papers)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Chen Liang
143 papers receiving 8.6k citations
Chen Liang's Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 1.5k
- Cancer Research 732
- Molecular Biology 1.6k
- Pulmonary and Respiratory Medicine 754
- Biomaterials 197
Countries citing papers authored by Chen Liang
This map shows the geographic impact of Chen Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Liang more than expected).
Fields of papers citing papers by Chen Liang
This network shows the impact of papers produced by Chen Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Liang. The network helps show where Chen Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives Hit paper breakdown → | 2021 | 1720 |
| 2 | Ferroptosis, necroptosis, and pyroptosis in anticancer immunity Hit paper breakdown → | 2020 | 1004 |
| 3 | 2017 | 272 | |
| 4 | 2021 | 232 | |
| 5 | 2019 | 224 | |
| 6 | Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives Hit paper breakdown → | 2022 | 200 |
| 7 | 2018 | 192 | |
| 8 | 1991 | 146 | |
| 9 | 2017 | 137 | |
| 10 | 2019 | 134 | |
| 11 | 2017 | 126 | |
| 12 | 2020 | 125 | |
| 13 | 2020 | 124 | |
| 14 | 2016 | 119 | |
| 15 | 1989 | 116 | |
| 16 | Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue. | 1991 | 110 |
| 17 | 1985 | 107 | |
| 18 | 2018 | 107 | |
| 19 | 2015 | 98 | |
| 20 | 2020 | 95 |
About Chen Liang
Chen Liang is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Immunology, having authored 148 papers that have together received 8.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (37 papers), Ferroptosis and cancer prognosis (5 papers), MicroRNA in disease regulation (5 papers), Gut microbiota and health (5 papers), Cancer-related molecular mechanisms research (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), RNA modifications and cancer (3 papers) and Signaling Pathways in Disease (2 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (732 citations), Molecular Biology (1.6k citations), Pulmonary and Respiratory Medicine (754 citations) and Biomaterials (197 citations). Chen Liang has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Xianjun Yu, Si Shi, Jin Xu, Qingcai Meng, Jie Hua, Jiang Liu, Bo Zhang, Wei Wang, Xiaoqi Mao and Bo Zhang. Their work appears in journals such as Frontiers in Oncology, Cell Death and Disease, Molecular Cancer, Journal of Biological Chemistry and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.